This inventor holds 1 USPTO granted patent. Top assignees: Sangamo Therapeutics, Inc., Takeda Pharmaceutical Company Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 154 
1 out of 1,226 
Years Active: 2026
Title: Matthew Chiocco: Innovator in Transcription Factor Technology
Introduction
Matthew Chiocco is a notable inventor based in Southborough, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of transcription factors. His work has implications for various applications in genetic research and therapeutic development.
Latest Patents
Matthew Chiocco holds a patent for "HTT repressors comprising a zinc-finger protein transcription factor." This innovation showcases his expertise in manipulating genetic elements to regulate gene expression, which is crucial for advancing therapeutic strategies.
Career Highlights
Throughout his career, Chiocco has worked with prominent companies in the biotechnology sector. He has been associated with Takeda Pharmaceutical Company Limited and Sangamo Therapeutics, Inc. His experience in these organizations has allowed him to collaborate on cutting-edge research and development projects.
Collaborations
Chiocco has worked alongside talented professionals, including Galen Carey and Vivian Choi. These collaborations have enriched his research and contributed to the advancement of innovative solutions in the field.
Conclusion
Matthew Chiocco is a distinguished inventor whose work in transcription factor technology has the potential to impact genetic research and therapeutic applications significantly. His contributions continue to inspire advancements in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile